| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 217,931 | 212,559 | 209,205 | 249,186 | | Cost of Revenue | 144,013 | 143,671 | 139,174 | 174,431 | | | Gross Profit | 73,918 | 68,888 | 70,031 | 74,755 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| 66,486 | | Selling General and Administrative | 61,173 | 64,633 | 67,619 | 3,881 | | Non Recurring | 21,242 | 33,810 | 17,179 | 97,133 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (8,497) | (29,555) | (14,767) | (92,745) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 8,086 | 36,318 | 702 | 2,592 | | Earnings Before Interest And Taxes | (17,103) | 6,763 | (14,065) | (90,153) | | Interest Expense | (11,920) | 5,203 | 6,717 | 7,225 | | Income Before Tax | (5,183) | 1,560 | (20,782) | (97,378) | | Income Tax Expense | 1,080 | 4,339 | (1,605) | (16,016) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (6,264) | (2,744) | (18,897) | (81,110) | | | Non-recurring Events | | Discontinued Operations |
-
| (10,000) |
-
| 198 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (6,264) | (12,744) | (18,897) | (80,912) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($6,264) | ($12,744) | ($18,897) | ($80,912) |
|
0.22% Nasdaq 
Income Statement
